home / stock / agnpf / agnpf quote
Last: | $0.091435 |
---|---|
Change Percent: | 0.8% |
Open: | $0.0865 |
Close: | $0.091435 |
High: | $0.091435 |
Low: | $0.0865 |
Volume: | 6,040 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.091435 | $0.0865 | $0.091435 | $0.091435 | $0.0865 | 6,040 | 04-26-2024 |
$0.0872 | $0.067 | $0.0872 | $0.0872 | $0.067 | 508 | 04-25-2024 |
$0.089 | $0.089 | $0.089 | $0.089 | $0.089 | 21,500 | 04-24-2024 |
$0.089 | $0.07885 | $0.089 | $0.089 | $0.07885 | 75,088 | 04-23-2024 |
$0.0716 | $0.0606 | $0.0716 | $0.0716 | $0.0606 | 12,208 | 04-22-2024 |
$0.0756 | $0.0639 | $0.0756 | $0.0756 | $0.0636 | 4,436 | 04-19-2024 |
$0.07083 | $0.07083 | $0.07083 | $0.07083 | $0.07083 | 1,304 | 04-18-2024 |
$0.06715 | $0.06715 | $0.06715 | $0.06715 | $0.06715 | 100 | 04-16-2024 |
$0.0682 | $0.0602 | $0.0682 | $0.0682 | $0.0602 | 304 | 04-15-2024 |
$0.0608 | $0.0796 | $0.0608 | $0.0796 | $0.0608 | 3,204 | 04-11-2024 |
$0.0715 | $0.0715 | $0.0715 | $0.0715 | $0.0715 | 198 | 04-10-2024 |
$0.08 | $0.08 | $0.08 | $0.08 | $0.08 | 8,362 | 04-09-2024 |
$0.0764 | $0.0839 | $0.0764 | $0.0865 | $0.0764 | 30,048 | 04-08-2024 |
$0.08 | $0 | $0.08 | $0 | $0 | 2,200 | 04-05-2024 |
$0.08 | $0.08 | $0.08 | $0.08 | $0.08 | 15,000 | 04-04-2024 |
$0.086 | $0.07936 | $0.086 | $0.086 | $0.07936 | 956 | 04-03-2024 |
$0.07268 | $0 | $0.07268 | $0 | $0 | 16 | 04-02-2024 |
$0.07268 | $0.0823 | $0.07268 | $0.086 | $0.07268 | 12,968 | 04-01-2024 |
$0.082 | $0.09142 | $0.082 | $0.0914 | $0.082 | 15,952 | 03-29-2024 |
$0.082 | $0.09142 | $0.082 | $0.09142 | $0.082 | 15,952 | 03-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Algernon Pharmaceuticals Inc - Class A Company Name:
AGNPF Stock Symbol:
OTCMKTS Market:
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the "Company" or "AGN Pharma") (CSE:AGN) (FRANKF...
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its...
VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") (CSE:AGN) (FRANKFUR...